International percutaneous coronary intervention complication survey

Bahadir Simsek; Spyridon Kostantinis; Judit Karacsonyi; Allison Hall; Bavana Venkata Rangan; Kevin J. Croce; Lorenzo Azzalini; Margaret McEntegart; Mehdi Shishehbor; Mohaned Egred; Olga C. Mastrodemos; Paul Sorajja; Subhash Banerjee; William Lombardi; Yader Sandoval; Emmanouil S. Brilakis

doi:10.1002/ccd.30173

International percutaneous coronary intervention complication survey

Bahadir Simsek, Spyridon Kostantinis, Judit Karacsonyi, Allison Hall, Bavana Venkata Rangan, Kevin J. Croce, Lorenzo Azzalini, Margaret McEntegart, Mehdi Shishehbor, Mohaned Egred, Olga C. Mastrodemos, Paul Sorajja, Subhash Banerjee, William Lombardi, Yader Sandoval, Emmanouil S. Brilakis

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Objectives: To investigate the perceptions of interventional cardiologists (IC) regarding the frequency, impact, and management strategies of percutaneous coronary intervention (PCI) complications. Background: The perceptions and management strategies of ICs of PCI complications have received limited study. Methods: Online survey on PCI complications: 46 questions were distributed via email lists and Twitter to ICs. Results: Of 11,663 contacts, 821 responded (7% response rate): 60% were from the United States and the median age was 46–50 years. Annual PCI case numbers were <100 (26%), 100–199 (37%), 200–299 (21%), and ≥300 (16%); 42% do not perform structural interventions, others reported performing <40 (30%), or >100 (11%) structural cases annually. On a scale of 0–10, participating ICs were highly concerned about potential complications with a median score of 7.2 (interquartile range: 5.0–8.7). The most feared complication was death (39%), followed by coronary perforation (26%) and stroke (9%). Covered stents were never deployed by 21%, and 32% deployed at least one during the past year; 79% have never used fat to seal perforations; 64% have never used coils for perforations. Complications were attributed to higher patient/angiographic complexity by 68% and seen as opportunities for improvement by 70%; 97% of participants were interested in learning more about the management of PCI complications. The most useful learning methods were meetings (66%), webinars (48%), YouTube (32%), and Twitter (29%). Conclusion: ICs who participated in the survey are highly concerned about complications. Following complication management algorithms and having access to more experienced operators might alleviate stress and optimize patient outcomes.

Original language	English (US)
Journal	Catheterization and Cardiovascular Interventions
DOIs	https://doi.org/10.1002/ccd.30173
State	Accepted/In press - 2022

Keywords

complications
coronary angiogram
interventional cardiology
percutaneous coronary intervention
survey

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ccd.30173

Cite this

Simsek, B., Kostantinis, S., Karacsonyi, J., Hall, A., Rangan, B. V., Croce, K. J., Azzalini, L., McEntegart, M., Shishehbor, M., Egred, M., Mastrodemos, O. C., Sorajja, P., Banerjee, S., Lombardi, W., Sandoval, Y., & Brilakis, E. S. (Accepted/In press). International percutaneous coronary intervention complication survey. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30173

Simsek, B, Kostantinis, S, Karacsonyi, J, Hall, A, Rangan, BV, Croce, KJ, Azzalini, L, McEntegart, M, Shishehbor, M, Egred, M, Mastrodemos, OC, Sorajja, P, Banerjee, S, Lombardi, W, Sandoval, Y & Brilakis, ES 2022, 'International percutaneous coronary intervention complication survey', Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30173

@article{ced4980230094e12a5ee7b8b27001156,

title = "International percutaneous coronary intervention complication survey",

abstract = "Objectives: To investigate the perceptions of interventional cardiologists (IC) regarding the frequency, impact, and management strategies of percutaneous coronary intervention (PCI) complications. Background: The perceptions and management strategies of ICs of PCI complications have received limited study. Methods: Online survey on PCI complications: 46 questions were distributed via email lists and Twitter to ICs. Results: Of 11,663 contacts, 821 responded (7% response rate): 60% were from the United States and the median age was 46–50 years. Annual PCI case numbers were <100 (26%), 100–199 (37%), 200–299 (21%), and ≥300 (16%); 42% do not perform structural interventions, others reported performing <40 (30%), or >100 (11%) structural cases annually. On a scale of 0–10, participating ICs were highly concerned about potential complications with a median score of 7.2 (interquartile range: 5.0–8.7). The most feared complication was death (39%), followed by coronary perforation (26%) and stroke (9%). Covered stents were never deployed by 21%, and 32% deployed at least one during the past year; 79% have never used fat to seal perforations; 64% have never used coils for perforations. Complications were attributed to higher patient/angiographic complexity by 68% and seen as opportunities for improvement by 70%; 97% of participants were interested in learning more about the management of PCI complications. The most useful learning methods were meetings (66%), webinars (48%), YouTube (32%), and Twitter (29%). Conclusion: ICs who participated in the survey are highly concerned about complications. Following complication management algorithms and having access to more experienced operators might alleviate stress and optimize patient outcomes.",

keywords = "complications, coronary angiogram, interventional cardiology, percutaneous coronary intervention, survey",

author = "Bahadir Simsek and Spyridon Kostantinis and Judit Karacsonyi and Allison Hall and Rangan, {Bavana Venkata} and Croce, {Kevin J.} and Lorenzo Azzalini and Margaret McEntegart and Mehdi Shishehbor and Mohaned Egred and Mastrodemos, {Olga C.} and Paul Sorajja and Subhash Banerjee and William Lombardi and Yader Sandoval and Brilakis, {Emmanouil S.}",

note = "Funding Information: The authors are grateful for the philanthropic support of generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A. Sens; Mrs. Diane and Dr. Cline Hickok; Mrs. Wilma and Mr. Dale Johnson; Mrs. Charlotte and Mr. Jerry Golinvaux Family Fund; the Roehl Family Foundation; and the Joseph Durda Foundation. The generous gifts of these donors to the Minneapolis Heart Institute Foundation's Science Center for Coronary Artery Disease helped support this project. Funding Information: Dr. Allison Hall received speaker fees/honoraria from Medtronic, OpSens Medical, and Cardiovascular Innovations Foundation. Dr. Kevin J. Croce is a Proctor/Consulting/Honoraria/Advisory Board with Abbott, Boston Scientific, Philips, Abiomed, Cordis, CSI, Takeda, Biotronik, Teleflex, and Dyad, and received grant/research support from Teleflex, Takeda, and Abbott. Dr. Lorenzo Azzalini received Honoraria from Abbott Vascular, Guerbet, Terumo, and Sahajanand Medical Technologies and research support from ACIST Medical Systems, Guerbet, and Terumo. Dr. Margaret McEntegart had a proctorship agreement with Boston Scientific. Dr. Mehdi Shishehbor is a consultant for Abbot Vascular, Medtronic, Boston Scientific, and Philips. Dr. Paul Sorajja is a consultant and served on Speakers Bureaus for Abbott Vascular, Medtronic, Boston Scientific, Edwards Lifesciences, Admedus, and Gore; and has received research support from Abbott Vascular, Medtronic, Boston Scientific, and Edwards Lifesciences. Dr. Subhash Banerjee received honoraria from Medtronic, Cordis, Livmor, and AngioSafe and institutional research grants from Boston Scientific Corporation, Chiesi. Dr. William Lombardi is a consultant for Abbott Vascular, Asahi Intec, BSC, Medtronic, and Teleflex; reports royalties from Asahi Intec; and salary from Philips. Dr. Yader Sandoval previously served on the Advisory Boards for Roche Diagnostics and Abbott Diagnostics without personal compensation and has also been a speaker without personal financial compensation for Abbott Diagnostics. Dr. Emmanouil S. Brilakis is a consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor ), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, IMDS, Medtronic, Siemens, and Teleflex; research support from Boston Scientific, GE Healthcare; owner, Hippocrates LLC; shareholder with MHI Ventures, Cleerly Health, and Stallion Medical. Other authors have no conflicts of interest. Circulation Publisher Copyright: {\textcopyright} 2022 Wiley Periodicals LLC.",

year = "2022",

doi = "10.1002/ccd.30173",

language = "English (US)",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - International percutaneous coronary intervention complication survey

AU - Simsek, Bahadir

AU - Kostantinis, Spyridon

AU - Karacsonyi, Judit

AU - Hall, Allison

AU - Rangan, Bavana Venkata

AU - Croce, Kevin J.

AU - Azzalini, Lorenzo

AU - McEntegart, Margaret

AU - Shishehbor, Mehdi

AU - Egred, Mohaned

AU - Mastrodemos, Olga C.

AU - Sorajja, Paul

AU - Banerjee, Subhash

AU - Lombardi, William

AU - Sandoval, Yader

AU - Brilakis, Emmanouil S.

N1 - Funding Information: The authors are grateful for the philanthropic support of generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A. Sens; Mrs. Diane and Dr. Cline Hickok; Mrs. Wilma and Mr. Dale Johnson; Mrs. Charlotte and Mr. Jerry Golinvaux Family Fund; the Roehl Family Foundation; and the Joseph Durda Foundation. The generous gifts of these donors to the Minneapolis Heart Institute Foundation's Science Center for Coronary Artery Disease helped support this project. Funding Information: Dr. Allison Hall received speaker fees/honoraria from Medtronic, OpSens Medical, and Cardiovascular Innovations Foundation. Dr. Kevin J. Croce is a Proctor/Consulting/Honoraria/Advisory Board with Abbott, Boston Scientific, Philips, Abiomed, Cordis, CSI, Takeda, Biotronik, Teleflex, and Dyad, and received grant/research support from Teleflex, Takeda, and Abbott. Dr. Lorenzo Azzalini received Honoraria from Abbott Vascular, Guerbet, Terumo, and Sahajanand Medical Technologies and research support from ACIST Medical Systems, Guerbet, and Terumo. Dr. Margaret McEntegart had a proctorship agreement with Boston Scientific. Dr. Mehdi Shishehbor is a consultant for Abbot Vascular, Medtronic, Boston Scientific, and Philips. Dr. Paul Sorajja is a consultant and served on Speakers Bureaus for Abbott Vascular, Medtronic, Boston Scientific, Edwards Lifesciences, Admedus, and Gore; and has received research support from Abbott Vascular, Medtronic, Boston Scientific, and Edwards Lifesciences. Dr. Subhash Banerjee received honoraria from Medtronic, Cordis, Livmor, and AngioSafe and institutional research grants from Boston Scientific Corporation, Chiesi. Dr. William Lombardi is a consultant for Abbott Vascular, Asahi Intec, BSC, Medtronic, and Teleflex; reports royalties from Asahi Intec; and salary from Philips. Dr. Yader Sandoval previously served on the Advisory Boards for Roche Diagnostics and Abbott Diagnostics without personal compensation and has also been a speaker without personal financial compensation for Abbott Diagnostics. Dr. Emmanouil S. Brilakis is a consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor ), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, IMDS, Medtronic, Siemens, and Teleflex; research support from Boston Scientific, GE Healthcare; owner, Hippocrates LLC; shareholder with MHI Ventures, Cleerly Health, and Stallion Medical. Other authors have no conflicts of interest. Circulation Publisher Copyright: © 2022 Wiley Periodicals LLC.

PY - 2022

Y1 - 2022

N2 - Objectives: To investigate the perceptions of interventional cardiologists (IC) regarding the frequency, impact, and management strategies of percutaneous coronary intervention (PCI) complications. Background: The perceptions and management strategies of ICs of PCI complications have received limited study. Methods: Online survey on PCI complications: 46 questions were distributed via email lists and Twitter to ICs. Results: Of 11,663 contacts, 821 responded (7% response rate): 60% were from the United States and the median age was 46–50 years. Annual PCI case numbers were <100 (26%), 100–199 (37%), 200–299 (21%), and ≥300 (16%); 42% do not perform structural interventions, others reported performing <40 (30%), or >100 (11%) structural cases annually. On a scale of 0–10, participating ICs were highly concerned about potential complications with a median score of 7.2 (interquartile range: 5.0–8.7). The most feared complication was death (39%), followed by coronary perforation (26%) and stroke (9%). Covered stents were never deployed by 21%, and 32% deployed at least one during the past year; 79% have never used fat to seal perforations; 64% have never used coils for perforations. Complications were attributed to higher patient/angiographic complexity by 68% and seen as opportunities for improvement by 70%; 97% of participants were interested in learning more about the management of PCI complications. The most useful learning methods were meetings (66%), webinars (48%), YouTube (32%), and Twitter (29%). Conclusion: ICs who participated in the survey are highly concerned about complications. Following complication management algorithms and having access to more experienced operators might alleviate stress and optimize patient outcomes.

AB - Objectives: To investigate the perceptions of interventional cardiologists (IC) regarding the frequency, impact, and management strategies of percutaneous coronary intervention (PCI) complications. Background: The perceptions and management strategies of ICs of PCI complications have received limited study. Methods: Online survey on PCI complications: 46 questions were distributed via email lists and Twitter to ICs. Results: Of 11,663 contacts, 821 responded (7% response rate): 60% were from the United States and the median age was 46–50 years. Annual PCI case numbers were <100 (26%), 100–199 (37%), 200–299 (21%), and ≥300 (16%); 42% do not perform structural interventions, others reported performing <40 (30%), or >100 (11%) structural cases annually. On a scale of 0–10, participating ICs were highly concerned about potential complications with a median score of 7.2 (interquartile range: 5.0–8.7). The most feared complication was death (39%), followed by coronary perforation (26%) and stroke (9%). Covered stents were never deployed by 21%, and 32% deployed at least one during the past year; 79% have never used fat to seal perforations; 64% have never used coils for perforations. Complications were attributed to higher patient/angiographic complexity by 68% and seen as opportunities for improvement by 70%; 97% of participants were interested in learning more about the management of PCI complications. The most useful learning methods were meetings (66%), webinars (48%), YouTube (32%), and Twitter (29%). Conclusion: ICs who participated in the survey are highly concerned about complications. Following complication management algorithms and having access to more experienced operators might alleviate stress and optimize patient outcomes.

KW - complications

KW - coronary angiogram

KW - interventional cardiology

KW - percutaneous coronary intervention

KW - survey

UR - http://www.scopus.com/inward/record.url?scp=85127337597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127337597&partnerID=8YFLogxK

U2 - 10.1002/ccd.30173

DO - 10.1002/ccd.30173

M3 - Article

C2 - 35349771

AN - SCOPUS:85127337597

SN - 1522-1946

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

ER -

International percutaneous coronary intervention complication survey

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this